NCT05959824 - Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions

Recurrent Aphthous Ulcer

Interventions

DEVICE

OR-AT0222

Topical viscous gel containing tamarind seed polysaccharide and isolated pea proteins will be used 3 times a day away from the main meals (breakfast lunch and dinner) for 7 days.

OTHER

Placebo

Topical placebo viscous gel will be used 3 times a day away from the main meals (breakfast lunch and dinner) for 7 days.

Trial Locations (1)

00161

RECRUITING

"Policlinico Umberto I - U.O.C. di Odontoiatria Pediatrica ed Odontostomatologia", Rome